ARIDIS PHARMACEUTICAL INC by Aridis Pharmaceuticals Inc. (ARDS) Stock Price, Quote, News & History

ARDSOTCEM

Trade with Public

$0.3101

At close: Jul 28, 5:00 PM EST

$0.00020

-0.31-99.94%

After Hours: Nov 10, 8:36 AM EST

OverviewNews Earnings Forecast Price Targets Financials Sentiment Ownership Compare

Key Statistics

Open

Volume / Avg.

0 / 34.98K

Day Range

- - -

52 Wk Range

0.00 - 0.05

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

9.92

Recent Aridis Pharmaceuticals Inc News

Why Lixte Biotechnology Shares Are Trading Lower By 26%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Gainers Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) gained 90% to $0.3560 after the company issued strategic update and announced restructuring.

Lisa Levin

Why Are Aridis Pharmaceuticals Shares Moving Higher Today?

Aridis Pharmaceuticals Inc (NASDAQ: ARDS) shares are gaining after announcing positive European Medicines Agency feedback on its proposed single confirmatory Phase 3 study of investigational monoclonal

Vandana Singh

Why Biophytis Shares Are Trading Higher By 54%; Here Are 20 Stocks Moving Premarket

Gainers Biophytis S.A. (NASDAQ: BPTS) shares surged 53.9% to $3.31 in pre-market trading after the company signed a partnership with SEQENS to produce Sarconeos (BIO101) active compound, the company's main product.

Lisa Levin

Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Gainers ProMIS Neurosciences, Inc. (NASDAQ: PMN) shares jumped 126.6% to $6.37. ProMIS showcased preclinical data at the Alzheimer's Association International Conference 2023 on computationally-derived antibody and vaccine from Alzheimer's pipeline.

Lisa Levin

Why State Street Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Gainers PainReform Ltd. (NASDAQ: PRFX) shares climbed 103% to $11.67. PainReform recently announced pricing of a $2.7 million concurrent registered direct offering and private placement.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-17.89M

Investing Cash Flow (TTM)

-35.00K

Financing Cash Flow (TTM)

15.32M

Free Cash Flow (TTM)

-17.93M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

-2.60M

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$4.81M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

Earnings Yield % (TTM)

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

Company Debt

Total Debt

$3.41M

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$35.00K

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

-$2.84M

Key Statistics

Open

Volume / Avg.

0 / 34.98K

Day Range

- - -

52 Wk Range

0.00 - 0.05

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

9.92

About

Sector

Health Care

Industry

Biotechnology

Aridis Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is engaged in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections.

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

ARDS

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

ARDS

FAQ

How do I buy ARIDIS PHARMACEUTICAL INC by Aridis Pharmaceuticals Inc. (ARDS) stock?

You can purchase shares of ARIDIS PHARMACEUTICAL INC by Aridis Pharmaceuticals Inc. (OTCEM:ARDS) through any online brokerage.

View our list of the best stock brokerages

Who are ARIDIS PHARMACEUTICAL INC by Aridis Pharmaceuticals Inc. (ARDS) competitors?

There are no as such competitors for ARIDIS PHARMACEUTICAL INC by Aridis Pharmaceuticals Inc..

What is the forecast, or price target, for ARIDIS PHARMACEUTICAL INC by Aridis Pharmaceuticals Inc. (ARDS) stock?

ARIDIS PHARMACEUTICAL INC by Aridis Pharmaceuticals Inc. has a consensus price target of $2.00.

What is the current price for ARIDIS PHARMACEUTICAL INC by Aridis Pharmaceuticals Inc. (ARDS)?

The stock price for ARIDIS PHARMACEUTICAL INC by Aridis Pharmaceuticals Inc. (OTCEM: ARDS) is $0.0001 last updated August 17, 2026 at 2:20 PM EDT.

Does ARIDIS PHARMACEUTICAL INC by Aridis Pharmaceuticals Inc. (ARDS) pay a dividend?

There are no upcoming dividends for ARIDIS PHARMACEUTICAL INC by Aridis Pharmaceuticals Inc..

When is ARIDIS PHARMACEUTICAL INC by Aridis Pharmaceuticals Inc. (OTCEM:ARDS) reporting earnings?

ARIDIS PHARMACEUTICAL INC by Aridis Pharmaceuticals Inc. does not have any upcoming earnings scheduled.

Is ARIDIS PHARMACEUTICAL INC by Aridis Pharmaceuticals Inc. (ARDS) going to split?

There is no upcoming split for ARIDIS PHARMACEUTICAL INC by Aridis Pharmaceuticals Inc..

What sector and industry does ARIDIS PHARMACEUTICAL INC by Aridis Pharmaceuticals Inc. (ARDS) operate in?

ARIDIS PHARMACEUTICAL INC by Aridis Pharmaceuticals Inc. is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.